Cerus: IFC Growth And RBC Optionality (NASDAQ:CERS)

Core Insights - Cerus Corporation (CERS) is a biotechnology company focused on developing transfusion-safety solutions to ensure a reliable and pathogen-reduced blood supply [1] Group 1: Company Overview - Cerus Corporation produces the Intercept Blood System, which includes devices, disposables, and consumables for platelets and plasma [1]